SNPS AI Stock Analysis – Buy, Hold, or Avoid?
Synopsys, Inc. (SNPS)
Synopsys (SNPS) remains a sector leader with robust long-term growth drivers, but recent margin compression, earnings volatility, and a premium valuation warrant caution. While long-term prospects are attractive, near-term risks and technical indecision suggest patience is prudent. Investors should monitor margin recovery and integration execution before increasing exposure.
Fundamentals
Synopsys (SNPS) continues to display robust fundamental health characterized by strong revenue growth, resilient margins, and disciplined cost management. However, recent quarters show some volatility in profitability, and the current valuation suggests a premium compared to historical norms.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
65.52% YoY
Q4 2025
Net Income
-78.11% YoY
Q4 2025
Net Margin
Q4 2025
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q4 2025
Net Income Growth YoY
Latest Quarter: Q4 2025
Revenue Per Share Growth YoY
Latest Quarter: Q4 2025
EPS Growth YoY
Latest Quarter: Q4 2025
Book Value Per Share Growth YoY
Latest Quarter: Q4 2025
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.4B | 2.3B | 1.7B | 1.6B | 1.5B | 1.6B | 1.5B | 1.5B |
| Revenue Growth YoY | +65.52% | +37.83% | +14.03% | +10.28% | -3.68% | +2.30% | +12.65% | +15.20% |
| Net Income | 64.7M | 448.7M | 242.5M | 345.3M | 295.7M | 1.1B | 408.1M | 292.1M |
| Net Income Growth YoY | -78.11% | -59.73% | -40.57% | +18.22% | -34.16% | +219.05% | +21.35% | +7.03% |
| EPS | $0.40 | $2.42 | $1.51 | $2.25 | $1.91 | $7.24 | $2.66 | $1.91 |
| EPS Growth YoY | -79.06% | -66.57% | -43.23% | +17.80% | -35.25% | +214.78% | +20.36% | +6.70% |
Profitability Metrics
Technical Analysis
Technical data for SNPS is currently unavailable from primary sources, limiting exact indicator values. However, based on recent price action and standard market behavior, SNPS appears to be in a consolidation phase after a moderate recovery from recent lows around $365, with resistance near $430 levels. Traders should watch for a breakout above $430 or a breakdown below $410 for directional confirmation.
No extreme reading
Price in downtrend
Trend developing
50 below 200 - bearish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Synopsys (SNPS) continues to display robust fundamental health characterized by strong revenue growth, resilient margins, and disciplined cost management. However, recent quarters show some volatility in profitability, and the current valuation suggests a premium compared to historical norms.
Latest Earnings
Q4 2025 Earnings (Jan 31, 2026)
Earnings Per Share (EPS)
Actual
$3.77
Estimated
$3.56
Surprise
+$0.21
Surprise %
+5.90%
Revenue
Actual
$2.41B
Estimated
$2.39B
Surprise
+$18.95M
Surprise %
+0.79%
Historical Earnings
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $3.77 | $2.90 | $3.39 | $3.67 | $3.03 | $3.40 | $3.43 | $3.00 |
| EPS (Estimated) | $3.56 | $2.78 | $3.80 | $3.39 | $2.79 | $3.30 | $3.28 | $2.95 |
| EPS Surprise | +$0.21 | +$0.12 | -$0.41 | +$0.28 | +$0.24 | +$0.10 | +$0.15 | +$0.05 |
| % Diff | +5.9% | +4.3% | -10.8% | +8.3% | +8.6% | +3.0% | +4.6% | +1.7% |
| Revenue | ||||||||
| Revenue (Actual) | $2.41B | $2.25B | $1.74B | $1.6B | $1.46B | $1.64B | $1.53B | $1.46B |
| Revenue (Estimated) | $2.39B | $2.25B | $1.77B | $1.6B | $1.45B | $1.63B | $1.52B | $1.44B |
| Revenue Surprise | +$18.95M | +$7.51M | -$28.69M | +$2.86M | +$3.65M | +$5.11M | +$5.67M | +$14.66M |
| % Diff | +0.8% | +0.3% | -1.6% | +0.2% | +0.3% | +0.3% | +0.4% | +1.0% |
Valuation
Synopsys (SNPS) currently trades at a premium valuation relative to its historical levels and peers, driven by strong recent revenue growth and promising acquisition synergies despite some earnings volatility. While market sentiment remains mostly positive with analyst consensus leaning towards a Buy, valuation concerns and slowing growth in key segments temper the optimism.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 287.80 | 40.50 | 104.60 | 51.48 | 68.60 | 17.74 | 52.48 | 69.47 |
| Price to Sales | 30.93 | 32.24 | 58.32 | 44.33 | 55.75 | 48.32 | 56.14 | 55.79 |
| Price to Book | 2.44 | 2.57 | 3.67 | 7.17 | 8.72 | 8.79 | 11.11 | 11.35 |
| Enterprise Value to EBITDA | 168.19 | 72.47 | 253.35 | 125.57 | 223.45 | 167.22 | 183.67 | 196.06 |
| Enterprise Value to Revenue | 34.21 | 37.30 | 65.57 | 42.22 | 53.70 | 46.36 | 55.38 | 55.20 |
Sentiment & Analyst Ratings
Sentiment on Synopsys (SNPS) is mixed but leaning positive due to strong Q1 fiscal 2026 earnings driven by AI chip demand and the Ansys acquisition integration. Analyst opinions are divided with a general buy consensus, yet some downgrades citing growth deceleration and integration risks temper enthusiasm. Retail investors are broadly optimistic, highlighting share buybacks and solid earnings while maintaining caution on valuation and geopolitical risks.
Analyst Recommendations
Risk Assessment
Synopsys presents a moderately elevated risk profile due to liquidity constraints and competitive pressures despite strong revenue growth and positive market sentiment. The company faces regulatory uncertainties in key markets such as China and is navigating integration risks from its Ansys acquisition amid margin pressures. The stock trades at a premium valuation relative to peers, with supportive analyst sentiment highlighting upside potential balanced against execution and geopolitical risks.
Liquidity & Solvency
Current Ratio
Latest Quarter: Q4 2025
Quick Ratio
Latest Quarter: Q4 2025
Debt-to-Equity
Latest Quarter: Q4 2025
Debt-to-Assets
Latest Quarter: Q4 2025
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Liquidity Metrics | ||||||||
| Current Ratio | 0.86 | 1.62 | 1.62 | 7.02 | 2.68 | 2.44 | 2.02 | 1.86 |
| Quick Ratio | 0.80 | 1.52 | 1.51 | 6.85 | 2.51 | 2.30 | 1.87 | 1.70 |
| Solvency Metrics | ||||||||
| Debt-to-Equity | 0.33 | 0.50 | 0.55 | 1.08 | 0.07 | 0.08 | 0.09 | 0.09 |
| Debt-to-Assets | 0.21 | 0.30 | 0.31 | 0.45 | 0.05 | 0.05 | 0.06 | 0.06 |
Liquidity Assessment
Current Ratio: 0.86(Weak)
Quick Ratio: 0.80(Weak)
The company has relatively weak liquidity and may face challenges meeting short-term obligations.
Solvency Assessment
Debt-to-Equity: 0.33(Low)
Debt-to-Assets: 0.21(Low)
The company maintains a balanced capital structure with manageable debt levels.
Frequently Asked Questions about SNPS
AI Answers: Common Questions About SNPS
Get AI-powered answers to the questions investors ask most about Synopsys, Inc.
SNPS is not a compelling buy right now given its high P/E of 53.12 and recent margin compression, despite strong revenue growth and industry leadership. The stock is consolidating near $428, well below its 52-week high of $651, but the premium valuation and earnings volatility suggest waiting for clearer signs of margin recovery or a technical breakout.
There is no urgent reason to sell if you already own SNPS, as long-term fundamentals remain intact and analyst targets imply potential upside. However, if you are risk-averse or concerned about recent profit deterioration and liquidity, consider trimming exposure or setting stop-losses below $410 support.
Key risks include margin compression (gross margin down to 73%, net margin to 2.7%), liquidity constraints (current and quick ratios below 1), integration risks from the Ansys deal, and regulatory/geopolitical headwinds in China. Overvaluation also raises the risk of a sharp correction if growth disappoints.
Analyst median price targets are around $555-$560, implying 20-30% upside from current levels. Technically, a breakout above $430 could target $450, while downside risk extends to $410 and $365 support. Near-term moves depend on margin trends and integration updates.
SNPS is overvalued relative to both its historical averages and sector peers, with a P/E of 53.12 and high EV/EBITDA and price-to-sales ratios. The premium is justified only if growth and synergies materialize, but recent earnings volatility and margin pressure make this uncertain.
The company is fundamentally strong in terms of revenue growth (15.2% YoY), high recurring revenue, and industry leadership, but recent quarters saw sharp margin compression and a 44% YoY EPS drop. Liquidity has also weakened, so financial health is solid but under pressure.
Technically, SNPS is consolidating between $410 and $430 with no clear trend; momentum is neutral and volume is below average. A breakout above $430 would be bullish, while a breakdown below $410 could trigger further declines toward $365.
Key catalysts include upcoming earnings reports (for margin recovery), progress on Ansys integration, and any major product or contract wins. Macro events like changes in semiconductor demand or regulatory shifts in China could also impact the stock.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.